Original Article Incidence and outcome of occult uterine sarcoma: A multi-centre study of 18604 operations performed for presumed uterine leiomyoma

摘要

The Food and Drug Administration (FDA) 2014 report that discouraged the use of laparoscopic power morcellation during laparoscopic hysterectomy or myomectomy raised a worldwide debate. [1] Minimally invasive surgery has several advantages such as decreased morbidity and length of hospital stay, and improved quality of life over conventional hysterectomy that cannot be discarded [2]. Nonetheless, inability to perform comprehensive surgical staging due to the destruction of surgical specimen and dissemination of sarcomatous tissue throughout peritoneal cavity are major concerns in cases of morcellated occult uterine sarcomas.